TickerKhojChemicals · Chemicals: Major Diversified · NSE: NEOCHEM · data 2026-11-02
Neochem Bio Solutions Ltd.
In plain words
Price: 13.1% below its 52-week high of ₹121.
A description of the data, not a recommendation.
Key figures
Growth
| Revenue (last 12 months) | ₹134 cr |
| Net profit (last 12 months) | ₹15 cr |
| Sales growth, 3 years (yearly) | 31.9% |
| Profit growth, 3 years (yearly) | 123.8% |
At a glance
P/E 11.0, P/B 2.1, dividend yield 0.0%. Price relative to earnings and book value (low is cheaper, not better).
ROE 24.4%, ROCE 32.0%, operating margin 16.4%: how much profit it earns on the money it uses.
Debt/equity 0.23, Profit growth 123.8% and sales growth 31.9% a year over 3 years.
Ratings use fixed thresholds on the latest reported figures. They describe the numbers and are not a recommendation.
Strengths and limitations
- High return on equity (24.4%).
- Profit grew 123.8% a year over 3 years.
None flagged by these rules.
Picked automatically from the latest reported figures with fixed rules; check the company's filings before relying on them.
Smart-money activity
5/100 · Weak over the last ~60 sessions
- Delivery vs usual 0/30: No stored daily delivery history for this stock (0 points).
- Bulk/block deals 0/20: Net −₹2.28 cr in bulk/block deals over 90 days (0 net buying days, 2 net selling days): more sold than bought.
- Insider / SAST buys 0/15: No insider buy or SAST acquisition filings in the last 90 days. Insider sells are not collected by the site, so only buy filings count.
- Mutual fund holding 0/15: No mutual fund scheme lists this stock. Latest monthly portfolios only (top 60 holdings per scheme); month-on-month change is not stored.
- Accumulation evidence 0/15: No accumulation evidence row (only saved-scan stocks have one; 0 points).
- Promoter pledges 5/5: No promoter pledge filings in 90 days.
A description of recorded activity (delivery, deals, insider buys, fund holding, pledges), not a recommendation. Today's most active stocks.
Story so far
● Deal
- 16 Sept 26Deal Bulk deal: SHEETAL SAGAR BUILDERS & DEVELOPERS… sold ₹1.27 cr +0.3% next session
- 10 Sept 26Deal Bulk deal: VORA PRITESH BIJAL sold ₹1.01 cr -4.9% next session
From official exchange filings and NSE data. How the price moved after an event describes the past, not what comes next.
Common questions
Is Neochem Bio Solutions Ltd. debt-free?
Its latest reported debt-to-equity ratio is 0.23.
What is Neochem Bio Solutions Ltd.'s P/E ratio?
About 11, based on the last 12 months' earnings and a price of ₹105.1 (data 2026-11-02).
What is the 52-week high and low of Neochem Bio Solutions Ltd.?
The 52-week high is ₹121 and the 52-week low is ₹63.
Compared with similar companies
| Company | Price | Market cap | P/E | P/B | ROE | ROCE | Debt/eq. | 1-yr return |
|---|---|---|---|---|---|---|---|---|
| Neochem Bio Solutions Ltd. | ₹105.1 | ₹180 cr | 11 | 2.1 | 24.4% | 32% | 0.23 | -2.7% |
| Chembond Material Technologies Limited | ₹178.8 | ₹238 cr | 15.9 | 1.4 | 8% | 9.3% | 0.02 | 0.0% |
| Diamines & Chemicals Ltd. | ₹229.8 | ₹226 cr | — | 1.5 | -8% | -10.2% | 0.05 | -17.2% |
| DCM Shriram Fine Chemicals Limited | ₹26.3 | ₹218 cr | — | — | — | — | — | -47.4% |
| Vikas EcoTech Limited | ₹0.98 | ₹173 cr | 490 | — | 0.4% | 0.7% | 0.08 | -48.4% |
| Chemcrux Enterprises Ltd. | ₹79.25 | ₹118 cr | 28.3 | — | 4.9% | 6.3% | 0.45 | -8.8% |
Compare NEOCHEM with CHEMBOND in detail →
The full analysis has the price chart, every quarterly result with YoY/QoQ growth, the balance sheet and cash flow with an accounting red-flag check, shareholding quarter by quarter with big investors, news, filings and bulk/block deals.
Open NEOCHEM in TickerKhoj →